MicroStrategy, now Strategy, posted a $12.44 billion net loss in Q4 2025 mainly due to a $17.44 billion unrealized loss on bitcoin. Despite a rally in its stock price driven by bitcoin treasury announcements, its core software business is small and unprofitable. CEO Phong Le plans to raise $25.3 billion in 2025 to buy more bitcoin, increasing financial risk. In contrast, CME Group reported strong Q1 2026 results with $1.88 billion revenue and $1.15 billion net income, diversified across multiple asset classes and offering steady dividends and buybacks. CME’s stable earnings and low beta make it a safer choice for long-term investors compared to MicroStrategy’s volatile bitcoin exposure and heavy dilution.
Zoomex, a global crypto derivatives exchange, has introduced Zoomex Stocks, allowing users to trade tokenized versions of major U.S. equities and ETFs using USDT within a single account. This move responds to a market shift as institutional capital f...
Shares of Strategy Inc. rose 7.5% following a surge in Bitcoin after the US and Iran announced a peace deal to end hostilities and reopen the Strait of Hormuz. This agreement boosted global risk appetite, lifting equities and lowering oil prices, whi...
The leveraged ETFs MSTX and MSTU, which aim to deliver twice the daily move of MicroStrategy (MSTR) stock, have suffered severe losses, dropping about 95% over the past year compared to MSTR's 67% decline. These ETFs use daily reset mechanics and syn...
SpaceX's $2 trillion IPO has highlighted the growing role of blockchain-based exchanges like Hyperliquid and Binance, which offered perpetual futures on SpaceX shares before the IPO. These futures, which have no expiration date, allowed traders early...
